Ophthotech Corp. | Ownership
Companies that own Ophthotech Corp.
D. E. Shaw & Co. LP
2,713,593
7.51%
63,619
0.01%
06/30/2018
Stonepine Capital Management LLC
1,912,018
5.29%
318,899
2.82%
06/30/2018
The Vanguard Group, Inc.
1,713,721
4.74%
73,734
0%
06/30/2018
AJO LP
1,473,107
4.08%
142,197
0.02%
06/30/2018
Sabby Capital LLC
1,310,078
3.62%
1,310,078
1.65%
06/30/2018
Acadian Asset Management LLC
1,164,268
3.22%
452,127
0.01%
06/30/2018
Renaissance Technologies LLC
984,698
2.72%
-259,882
0%
06/30/2018
Tamarack Advisers LP
925,000
2.56%
76,160
0.7%
06/30/2018
Morgan Stanley & Co. LLC
918,318
2.54%
300,522
0%
06/30/2018
Dimensional Fund Advisors LP
867,096
2.4%
303,825
0%
06/30/2018
| Address |
One Penn Plaza
New York New York 10119
United States
|
|
Employees
|
- |
| Website |
http://www.ophthotech.com |
| Updated |
09/14/2018 |
| Ophthotech Corp. is a biopharmaceutical company,which engages in discovering, developing, and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. |
